Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06585852
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-01
Brief Title:
Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid RGD in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy of Xenograft Alone or Mixed With Arginyl-Glycyl-Aspartic Acid RGD in Horizontal Ridge Augmentation With Split-crest Technique for Implant Placement A Randomized Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the present study is to evaluate the efficacy of xenograft alone or xenograft mixed with Arginylglycylaspartic acid RGD in horizontal ridge augmentation with split-crest technique for implant placement
Detailed Description:
A comparative study for ridge augmentation procedure With two groups First group underwent a surgical ridge splitting procedure with ultrasonic bone surgery and grafting with Xenograft alone and implant placement Second group underwent a surgical ridge splitting procedure with ultrasonic bone surgery Xenograft mix ed with Arginylglycylaspartic acid RGD and implant placement
Both groups were followed up for 1 and 3 months after loading
Both groups were followed up for 1 and 3 months after loading
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None